PP

Paul Ponath

MP Millennium Pharmaceuticals: 19 patents #23 of 771Top 3%
GI Gitr: 7 patents #1 of 5Top 20%
Merck: 5 patents #2,116 of 9,382Top 25%
CC Children'S Medical Center: 4 patents #177 of 1,211Top 15%
BH Brigham and Women's Hospital: 4 patents #209 of 1,764Top 15%
BS Bristol-Myers Squibb: 1 patents #2,477 of 3,969Top 65%
Overall (All Time): #92,443 of 4,157,543Top 3%
36
Patents All Time

Issued Patents All Time

Showing 25 most recent of 36 patents

Patent #TitleCo-InventorsDate
12331121 Efflux pump-cancer antigen multi-specific antibodies and compositions, reagents, kits and methods related thereto William Robert Arathoon, Evan Matthew Bishop, Raffaella Briante, Alissa Loren Briggs, Suchismita Mohanty +2 more 2025-06-17
11104739 Combination therapy using an anti-fucosyl-GM1 antibody and an anti-CD137 antibody Josephine M. Cardarelli, Daniel E. LOPES de MENEZES, Bingliang Chen, Chin Pan 2021-08-31
10570209 Methods for inducing or enhancing an immune response by administering agonistic glucocorticoid-induced TNFR-family-related receptor (GITR) antibodies L. Mary Smith, Grazyna Szymanska, Michael Rosenzweig, Jose F. Ponte 2020-02-25
10030074 Methods of inducing or enhancing an immune response in a subject having cancer by administering GITR antibodies L. Mary Smith, Grazyna Szymanska, Michael Rosenzweig, Jose F. Ponte 2018-07-24
9828425 Anti-ILT5 antibodies and ILT5-binding antibody fragments Irina Apostolou, Joe Ponte, Michael Rosenzweig 2017-11-28
9534051 Immunoregulation by anti-ILT5 antibodies and ILT5-binding antibody fragments Irina Apostolou, Joe Ponte, Michael Rosenzweig, Lou Vaickus 2017-01-03
9493572 GITR antibodies and methods of inducing or enhancing an immune response L. Mary Smith, Grazyna Szymanska, Michael Rosenzweig, Jose F. Ponte 2016-11-15
9353184 Humanized anti-CCR2 antibodies and methods of use therefor Theresa O'Keefe 2016-05-31
9241992 Combination therapies employing GITR binding molecules Jose F. Ponte, Michael Rosenzweig 2016-01-26
9028823 Methods of inducing or enhancing an immune response in a subject by administering agonistic GITR binding antibodies L. Mary Smith, Grazyna Szymanska, Michael Rosenzweig, Jose F. Ponte 2015-05-12
9023997 Anti-ILT5 antibodies and ILT5-binding antibody fragments Irina Apostolou, Joe Ponte, Michael Rosenzweig 2015-05-05
8901281 ILT3 binding molecules and uses therefor Patricia Rao, Michael Rosenzweig, L. Mary Smith, Jose F. Ponte 2014-12-02
8846397 Immunoregulation by anti-ILT5 antibodies and ILT5-binding antibody fragments Irina Apostolou, Joe Ponte, Michael Rosenzweig, Lou Vaickus 2014-09-30
8753828 Humanized anti-CCR2 antibodies and methods of use therefor Theresa O'Keefe 2014-06-17
8591886 Combination therapies employing GITR binding molecules Michael Rosenzweig, Jose F. Ponte 2013-11-26
8388967 Methods for inducing or enhancing an immune response by administering agonistic GITR-binding antibodies L. Mary Smith, Grazyna Szymanska, Michael Rosenzweig, Jose F. Ponte 2013-03-05
7858326 Method of diagnosis of inflammatory disease using eotaxin antibodies Shixin Qin, Douglas Ringler, Walter Newman, Charles Mackay 2010-12-28
7812135 GITR-binding antibodies L. Mary Smith, Grazyna Szymanska, Michael Rosenzweig, Jose F. Ponte 2010-10-12
7777008 ILT3 binding molecules and uses therefor Michael Rosenzweig, Jose F. Ponte 2010-08-17
7485301 Methods of treating inflammatory disease using antibodies which bind GPR-9-6 David Andrew, Brian A. Zabel 2009-02-03
7423129 Antibodies to human eotaxin Shixin Qin, Douglas Ringler, Walter Newman, Charles Mackay 2008-09-09
7402410 Humanized immunoglobulin reactive with α4β7 integrin Douglas Ringler, S. Tarran Jones, Walter Newman, Jose Saldanha, Mary M. Bendig 2008-07-22
7402657 C-C chemokine receptor 3 proteins Craig Gerard, Norma P. Gerard, Charles Mackay, Theodore W. Post, Shixin Qin 2008-07-22
7381412 Anti-TECK antibodies and methods of use therefor David Andrew, Brian A. Zabel 2008-06-03
7285620 Human chemotactic cytokine Shixin Qin, Douglas Ringler, Walter Newman, Charles Mackay 2007-10-23